AHA asks Sebelius to scale back meaningful use requirements

Share this article:

In a letter to Health and Human Services Secretary Kathleen Sebelius, the American Hospital Association said it has found that hospitals have significantly less flexibility when it comes to demonstrating "meaningful use" of electronic medical records.

"The Office of the National Coordinator for Health Information Technology requires hospitals to have in place EHRs that have been certified against all 24 objectives of meaningful use, not just the 19 that the CMS rule requires them to use to demonstrate meaningful use," according to the AHA. Healthcare providers can receive as much as $44,000 through Medicare and $63,750 through Medicaid for implementation and meaningful use of certified EHRs, according to the Centers for Medicare & Medicaid Services in July.

"AHA continues to believe that hospitals should be required to have EHR technology certified against only those objectives they will use to demonstrate meaningful use, so that they can exercise the flexibility CMS offered in its final rule," the association noted in its letter. "In looking carefully at the regulatory text in both the ONC and CMS final rules, the AHA believes that there are alternative interpretations of the existing regulations that address this problem."
Share this article:
close

Next Article in News

More in News

Large hepatitis outbreak reaches 47 cases, podiatry company denies ManorCare's charges

The number of people infected in an infamous North Dakota Hepatitis C outbreak has risen, state health officials say.

National Quality Forum supports quality measures in bill to standardize post-acute assessments

National Quality Forum supports quality measures in bill ...

The National Quality Forum has come out in strong support of a proposed standardized quality measures, such as skin integrity, across different types of post-acute care settings. Uniform assessments are ...

CMS changes mind on hospice drugs

The Centers for Medicaid & Medicare Services has revised guidance on authorization of hospice drugs for those under Medicare Advantage and Part D plans, according to a new memo.